AK
Anu Kant Mital
About Anu Kant Mital
Data last updated:
Anu Kant Mital has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Behavioural And Neuro Sciences Academy Of India and Ava Neuropsychiatry Research Foundation. Formerly with 2 companies, such as Sarvam Global Lifecare Private Limited and Sarvam Global Healthcare Llp. Engaged in General Business, Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Behavioural And Neuro Sciences Academy Of India U85110DL2010NPL200958 | Director | 31 Mar 2010 | 2010 | Active |
Ava Neuropsychiatry Research Foundation U72200MH2023NPL403181 | Director | 18 May 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sarvam Global Lifecare Private Limited U74999MH2018PTC316434 | Director | 27 Oct 2018 | 2018 | Active |
Sarvam Global Healthcare Llp AAE-9074 | Designated Partner | 12 Oct 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anu Kant Mital
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anu Kant Mital
Anu Kant Mital has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Behavioural And Neuro Sciences Academy Of India and Ava Neuropsychiatry Research Foundation. Formerly with 2 companies, such as Sarvam Global Lifecare Private Limited and Sarvam Global Healthcare Llp. Engaged in General Business, Healthcare.
Anu Kant Mital is associated with 2 companies as Director.
Anu Kant Mital has expertise in General Business, Healthcare.
Anu Kant Mital has 16 years in corporate governance.